TF
Tompkins Financial’s NovoCure NVCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $890 | Hold |
50
| – | – | ﹤0.01% | 524 |
|
|
2025
Q1 | $891 | Sell |
50
-50
| -50% | -$891 | ﹤0.01% | 539 |
|
|
2024
Q4 | $2.98K | Hold |
100
| – | – | ﹤0.01% | 482 |
|
|
2024
Q3 | $1.56K | Hold |
100
| – | – | ﹤0.01% | 541 |
|
|
2024
Q2 | $1.71K | Hold |
100
| – | – | ﹤0.01% | 548 |
|
|
2024
Q1 | $1.56K | Hold |
100
| – | – | ﹤0.01% | 583 |
|
|
2023
Q4 | $1.49K | Hold |
100
| – | – | ﹤0.01% | 601 |
|
|
2023
Q3 | $1.62K | Hold |
100
| – | – | ﹤0.01% | 544 |
|
|
2023
Q2 | $4.15K | Hold |
100
| – | – | ﹤0.01% | 526 |
|
|
2023
Q1 | $6.01K | Hold |
100
| – | – | ﹤0.01% | 522 |
|
|
2022
Q4 | $7K | Hold |
100
| – | – | ﹤0.01% | 510 |
|
|
2022
Q3 | $8K | Hold |
100
| – | – | ﹤0.01% | 496 |
|
|
2022
Q2 | $7K | Hold |
100
| – | – | ﹤0.01% | 497 |
|
|
2022
Q1 | $8K | Buy |
+100
| New | +$8K | ﹤0.01% | 505 |
|